Skip to main content
Top
Published in: Digestive Diseases and Sciences 6/2022

04-06-2021 | Colonoscopy | Original Article

Ten or More Cumulative Lifetime Adenomas Are Associated with Increased Risk for Advanced Neoplasia and Colorectal Cancer

Authors: Brian A. Sullivan, Thomas S. Redding IV, Xuejun Qin, Ziad F. Gellad, Elizabeth R. Hauser, Meghan C. O’Leary, Christina D. Williams, Laura W. Musselwhite, David Weiss, Ashton N. Madison, David Lieberman, Dawn Provenzale

Published in: Digestive Diseases and Sciences | Issue 6/2022

Login to get access

Abstract

Background

Colorectal cancer (CRC) screening guidelines recommend frequent colonoscopies and consideration of genetic testing in individuals with ≥10 cumulative adenomas. However, it is unclear how these guidelines apply to routine practice.

Aims

We estimated the proportion of participants found to have ≥10 cumulative adenomas in a screening population and described their outcomes of advanced neoplasia (AN), CRC, and extra-colonic malignancy.

Methods

We performed a secondary analysis of VA CSP#380, which includes 3121 veterans aged 50–75 who were followed up to 10 years after screening colonoscopy. We calculated the cumulative risk of ≥10 cumulative adenomas by Kaplan–Meier method. We compared baseline risk factors in those with and without ≥10 cumulative adenomas as well as the risk for AN (adenoma ≥1 cm, villous adenoma or high-grade dysplasia, or CRC) and extra-colonic malignancy by multivariate logistic regression.

Results

The cumulative risk of ≥10 cumulative adenomas over 10.5 years was 6.51% (95% CI 4.38%–9.62%). Age 60–69 or 70–75 at baseline colonoscopy was the only factors associated with the finding of ≥10 cumulative adenomas. Compared to those with 0–9 cumulative adenomas, participants with ≥10 cumulative adenomas were more likely to have had AN (OR 17.03; 95% CI 9.41–30.84), including CRC (OR 7.00; 95% CI 2.84–17.28), but not extra-colonic malignancies.

Conclusions

Approximately 6.5% of participants in this screening population were found to have ≥10 cumulative adenomas over 10.5 years, which was uncommon before age 60. These participants were found to have AN and CRC significantly more often compared to those with lower cumulative adenomas.
Literature
3.
go back to reference Syngal S, Brand R, Church JM et al. ACG clinical guideline: genetic testing and management of hereditary gastrointestinal cancer syndromes. Am J Gastroenterol. 2015;110:223–262.CrossRef Syngal S, Brand R, Church JM et al. ACG clinical guideline: genetic testing and management of hereditary gastrointestinal cancer syndromes. Am J Gastroenterol. 2015;110:223–262.CrossRef
4.
go back to reference Grover S, Kastrinos F, Steyerberg EW et al. Prevalence and phenotypes of APC and MUTYH mutations in participants with multiple colorectal adenomas. JAMA 2012;308:485–492.CrossRef Grover S, Kastrinos F, Steyerberg EW et al. Prevalence and phenotypes of APC and MUTYH mutations in participants with multiple colorectal adenomas. JAMA 2012;308:485–492.CrossRef
5.
go back to reference Stanich PP, Pearlman R, Hinton A et al. Prevalence of germline mutations in polyposis and colorectal cancer–associated genes in patients with multiple colorectal polyps. Clin Gastroenterol Hepatol 2019;17:2008-2015.e3.CrossRef Stanich PP, Pearlman R, Hinton A et al. Prevalence of germline mutations in polyposis and colorectal cancer–associated genes in patients with multiple colorectal polyps. Clin Gastroenterol Hepatol 2019;17:2008-2015.e3.CrossRef
6.
go back to reference Tieu AH, Edelstein D, Axilbund J et al. Clinical characteristics of multiple colorectal adenoma patients without germline APC or MYH mutations. J Clin Gastroenterol 2016;50:584–588.CrossRef Tieu AH, Edelstein D, Axilbund J et al. Clinical characteristics of multiple colorectal adenoma patients without germline APC or MYH mutations. J Clin Gastroenterol 2016;50:584–588.CrossRef
7.
go back to reference Kallenberg FGJ, Latchford A, Lips NC, Aalfs CM, Bastiaansen BAJ, Clark SK, Dekker E. Duodenal adenomas in patients with multiple colorectal adenomas without germline APC or MUTYH mutations. Dis Colon Rectum 2018;61:58–66.CrossRef Kallenberg FGJ, Latchford A, Lips NC, Aalfs CM, Bastiaansen BAJ, Clark SK, Dekker E. Duodenal adenomas in patients with multiple colorectal adenomas without germline APC or MUTYH mutations. Dis Colon Rectum 2018;61:58–66.CrossRef
8.
go back to reference Lieberman DA, Weiss DG, Bond JH et al. Use of colonoscopy to screen asymptomatic adults for colorectal cancer. N Engl J Med 2000;343:162–168.CrossRef Lieberman DA, Weiss DG, Bond JH et al. Use of colonoscopy to screen asymptomatic adults for colorectal cancer. N Engl J Med 2000;343:162–168.CrossRef
9.
go back to reference Lieberman D, Sullivan BA, Hauser ER et al. Baseline colonoscopy findings associated with 10-year outcomes in a screening cohort undergoing colonoscopy surveillance. Gastroenterology 2020;158:862-874.e8.CrossRef Lieberman D, Sullivan BA, Hauser ER et al. Baseline colonoscopy findings associated with 10-year outcomes in a screening cohort undergoing colonoscopy surveillance. Gastroenterology 2020;158:862-874.e8.CrossRef
10.
go back to reference Lieberman DA, Prindiville S, Weiss DG et al. Risk factors for advanced colonic neoplasia and hyperplastic polyps in asymptomatic individuals. JAMA 2003;290:2959–2967.CrossRef Lieberman DA, Prindiville S, Weiss DG et al. Risk factors for advanced colonic neoplasia and hyperplastic polyps in asymptomatic individuals. JAMA 2003;290:2959–2967.CrossRef
13.
go back to reference He X, Wu K, Ogino S et al. Association between risk factors for colorectal cancer and risk of serrated polyps and conventional adenomas. Gastroenterology 2018;155:355–373.CrossRef He X, Wu K, Ogino S et al. Association between risk factors for colorectal cancer and risk of serrated polyps and conventional adenomas. Gastroenterology 2018;155:355–373.CrossRef
14.
go back to reference Gupta S, Lieberman D, Anderson JC et al. Recommendations for follow-up after colonoscopy and polypectomy: a consensus update by the US multi-society task force on colorectal cancer. Gastrointest Endosc 2020;91:463-485.e5.CrossRef Gupta S, Lieberman D, Anderson JC et al. Recommendations for follow-up after colonoscopy and polypectomy: a consensus update by the US multi-society task force on colorectal cancer. Gastrointest Endosc 2020;91:463-485.e5.CrossRef
15.
go back to reference Martinez ME, Baron JA, Lieberman DA et al. A pooled analysis of advanced colorectal neoplasia diagnoses following colonoscopic polypectomy. Gastroenterology 2009;136:832–841.CrossRef Martinez ME, Baron JA, Lieberman DA et al. A pooled analysis of advanced colorectal neoplasia diagnoses following colonoscopic polypectomy. Gastroenterology 2009;136:832–841.CrossRef
16.
go back to reference Robertson DJ, Greenberg ER, Beach M et al. Colorectal cancer in participants under close colonoscopic surveillance. Gastroenterology 2005;129:34–41.CrossRef Robertson DJ, Greenberg ER, Beach M et al. Colorectal cancer in participants under close colonoscopic surveillance. Gastroenterology 2005;129:34–41.CrossRef
17.
go back to reference Robertson DJ, Burke CA, Welch G et al. Using the results of a baseline and a surveillance colonoscopy to predict recurrent adenomas with high-risk characteristics. Ann Intern Med 2009;151:103–109.CrossRef Robertson DJ, Burke CA, Welch G et al. Using the results of a baseline and a surveillance colonoscopy to predict recurrent adenomas with high-risk characteristics. Ann Intern Med 2009;151:103–109.CrossRef
18.
go back to reference Rex DK, Schoenfeld PS, Cohen J et al. Quality indicators for colonoscopy. Gastrointest Endosc 2015;81:31–53.CrossRef Rex DK, Schoenfeld PS, Cohen J et al. Quality indicators for colonoscopy. Gastrointest Endosc 2015;81:31–53.CrossRef
19.
go back to reference Yurgelun MB, Kulke MH, Fuchs CS et al. Cancer susceptibility gene mutations in individuals with colorectal cancer. J Clin Oncol 2017;35:1086–1095.CrossRef Yurgelun MB, Kulke MH, Fuchs CS et al. Cancer susceptibility gene mutations in individuals with colorectal cancer. J Clin Oncol 2017;35:1086–1095.CrossRef
20.
go back to reference Jeon J, Du M, Schoen RE et al. Determining risk of colorectal cancer and starting age of screening based on lifestyle, environmental, and genetic factors. Gastroenterology 2018;154:2152–2164.CrossRef Jeon J, Du M, Schoen RE et al. Determining risk of colorectal cancer and starting age of screening based on lifestyle, environmental, and genetic factors. Gastroenterology 2018;154:2152–2164.CrossRef
21.
go back to reference Park SK, Hwang SW, Kim KO et al. Risk of advanced colorectal neoplasm in participants with more than 10 adenomas on index colonoscopy: a Korean Association for the Study of Intestinal Diseases (KASID) study. J Gastroenterol Hepatol 2017;32:803–808.CrossRef Park SK, Hwang SW, Kim KO et al. Risk of advanced colorectal neoplasm in participants with more than 10 adenomas on index colonoscopy: a Korean Association for the Study of Intestinal Diseases (KASID) study. J Gastroenterol Hepatol 2017;32:803–808.CrossRef
22.
go back to reference Thirlwell C, Howarth KM, Segditsas S et al. Investigation of pathogenic mechanisms in multiple colorectal adenoma patients without germline APC or MYH/MUTYH mutations. Br J Cancer 2007;96:1729–1734.CrossRef Thirlwell C, Howarth KM, Segditsas S et al. Investigation of pathogenic mechanisms in multiple colorectal adenoma patients without germline APC or MYH/MUTYH mutations. Br J Cancer 2007;96:1729–1734.CrossRef
23.
go back to reference Okabayashi K, Ashrafian H, Hasegawa H et al. Body mass index category as a risk factor for colorectal adenomas: a systematic review and meta-analysis. Am J Gastroenterol 2012;107:1175–1185.CrossRef Okabayashi K, Ashrafian H, Hasegawa H et al. Body mass index category as a risk factor for colorectal adenomas: a systematic review and meta-analysis. Am J Gastroenterol 2012;107:1175–1185.CrossRef
24.
go back to reference Reid ME, Marshall JR, Roe D et al. Smoking exposure as a risk factor for prevalent and recurrent colorectal adenomas. Cancer Epidemiol Biomarkers Prev 2003;12:1006–1011.PubMed Reid ME, Marshall JR, Roe D et al. Smoking exposure as a risk factor for prevalent and recurrent colorectal adenomas. Cancer Epidemiol Biomarkers Prev 2003;12:1006–1011.PubMed
25.
go back to reference Sullivan BA, Qin X, Redding TS et al. Genetic colorectal cancer and adenoma risk variants are associated with increasing cumulative adenoma counts. Cancer Epidemiol Biomarkers Prev 2020;29:2269–2276.CrossRef Sullivan BA, Qin X, Redding TS et al. Genetic colorectal cancer and adenoma risk variants are associated with increasing cumulative adenoma counts. Cancer Epidemiol Biomarkers Prev 2020;29:2269–2276.CrossRef
Metadata
Title
Ten or More Cumulative Lifetime Adenomas Are Associated with Increased Risk for Advanced Neoplasia and Colorectal Cancer
Authors
Brian A. Sullivan
Thomas S. Redding IV
Xuejun Qin
Ziad F. Gellad
Elizabeth R. Hauser
Meghan C. O’Leary
Christina D. Williams
Laura W. Musselwhite
David Weiss
Ashton N. Madison
David Lieberman
Dawn Provenzale
Publication date
04-06-2021
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 6/2022
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-021-07069-0

Other articles of this Issue 6/2022

Digestive Diseases and Sciences 6/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.